|
시장보고서
상품코드
2039020
이식형 약물전달 기기 시장 : 제품 유형별, 기술별, 용도별, 지역별Implantable Drug Delivery Devices Market, By Product Type, By Technology, By Application, By Geography |
||||||
이식형 약물전달 기기 시장은 2026년에 316억 달러로 추정되며, 2033년까지 526억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 8.8%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 316억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 8.80% | 2033년 시장 규모 예측: | 526억 달러 |
이식형 약물전달 기기(이식형 약물 방출 기기라고도 함)는 체내에 이식하면 표적 부위에 국소적으로 약물을 전달할 수 있습니다. 혈관 스텐트, 전기 자극 기기, 정형외과용 기기 등 다양한 이식형 약물전달 기기를 사용할 수 있습니다. 또한, 이식형 기기는 약물과 결합하여 주요 작용 부위에 약물을 전달할 수도 있습니다. 따라서 호르몬 장애, 심혈관질환, 종양학, 안과 등의 분야에서 많은 약물요법이 개발되어 왔습니다.
약물전달 시스템에는 생분해성과 비생분해성 두 가지 유형이 있습니다. 생분해성 약물 용출 기기(생체흡수성이라고도 함)는 폴리에스테르아미드(PEA), 폴리락트산-코-글리콜산(PLGA) 등 생체적합성 물질을 사용하여 약물을 전달하고, 이식 후 시간이 지남에 따라 분해되는 기기입니다. 반면, 비생분해성 약물 방출 기기(바이오듀러블이라고도 함)는 실리콘 고무(폴리디메틸실록산, PDMS), 폴리에틸렌 비닐 아세테이트(EVA), 열가소성 폴리우레탄(TPU) 등의 생체적합성 재료를 사용하여 약물을 방출합니다. 비생분해성 약물 용출형 기기는 약물 보충(예 : 주사를 통한)이 가능하며, 기기를 제거하면 그 효과가 거의 즉시 사라집니다.
시장 역학
예측 기간 동안 신제품 출시 증가는 세계 임플란트 약물전달 기기 시장의 성장을 견인할 것으로 예상됩니다. 예를 들어, 2019년 오큘러 테라퓨틱스(Ocular Therapeutics)는 미국 시장에 덱스텐자(Dextenza) 안구 내 삽입물을 출시했습니다. 덱스텐자 안구 내 삽입물은 안과 수술 후 통증을 완화하기 위해 0.4mg의 덱사메타손을 방출하도록 설계된 안구 내 삽입물입니다. 이는 클리닉에서 시술 후 최대 30일 동안 약물을 전달할 수 있습니다.
각 사들은 세계 시장에서의 제품 판매 확대를 위해 규제 당국의 승인을 받기 위해 노력하고 있습니다. 예를 들어, 2018년 United Therapeutics Corporation은 미국 식품의약국(FDA)으로부터 Remodulin(Treprostinil) 주사제를 이식형 시스템에 사용하는 것에 대한 승인을 받았습니다. 레모듈린의 이식형 시스템은 전체 투여 시스템이 환자의 체내에 이식되어 의료진이 처방된 용량에 따라 최대 16주 간격으로 주사바늘을 통해 환자의 피부를 통해 약물을 보충하는 방식입니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트도 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 임플란트 약물전달 기기 시장의 주요 기업 프로파일을 작성했습니다. 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 및 전략, 향후 계획 등을 소개합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계 이식형 약물전달 기기 시장' 보고서는 투자자, 공급업체, 이식형 약물전달 기기 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 이식형 약물전달 기기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 개요
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 이식형 약물전달 기기 시장 : 제품 유형별, 2026-2033년
제5장 세계의 이식형 약물전달 기기 시장 : 기술별, 2026-2033년
제6장 세계의 이식형 약물전달 기기 시장 : 용도별, 2026-2033년
제7장 세계의 이식형 약물전달 기기 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.04Implantable Drug Delivery Devices Market is estimated to be valued at USD 31.6 Bn in 2026 and is expected to reach USD 52.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 31.6 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.80% | 2033 Value Projection: | USD 52.6 Bn |
Implantable drug delivery devices, also called as implantable drug eluting devices, allow targeted and localized drug delivery once the device is implanted in the body. There are various implantable drug delivery devices available such as vascular stents, electro stimulation devices, orthopedic devices, and others. An implantable device also delivers drugs to the primary site of action, when it is combined with the drugs. Thus, many drug therapies have been developed for hormonal disorders, cardiovascular disorders, oncology, ophthalmology, and others.
There are two types of drug delivery systems: biodegradable and non-biodegradable. Biodegradable drug-eluting devices (also referred to as bioerodible) use biocompatible materials such as polyesteramide (PEA) and Poly Lactic-co-Glycolic Acid (PLGA) to deliver drugs and once implanted, it decomposes over time. On the other hand, non-biodegradable drug-eluting devices (also referred to as biodurable) use biocompatible materials such as silicone rubber (polydimethylsiloxane or PDMS), polyethylene-vinyl acetate (EVA), and thermoplastic polyurethane (TPU) to deliver drugs. Non-biodegradable drug-eluting devices can be refilled with medication (eg, via injection) and the device's effects are almost immediately reversible upon removal.
Market Dynamics
Increasing product launches is expected to drive the global implantable drug delivery devices market growth over the forecast period. For instance, in 2019, Occular Therapeutics launched Dextenza ophthalmic insert in the U.S. market. Dextenza ophthalmic insert is an ocular insert that is designed to release 0.4 mg of dexamethasone to relieve pain after ophthalmic surgery. It can deliver drugs for up to 30 days after treatment in a physician's office.
Companies are engaged in receiving approvals from the regulatory authorities for further marketing the products in the global market. For instance, in 2018, United Therapeutics Corporation received the U.S Food and Drug Administration (FDA) approval for the use of Remodulin (treprostinil) injection in the implantable system. In the Remodulin implantable system, the entire delivery system is implanted into the patient's body and the system is refilled by healthcare professionals at an interval of up to 16 weeks depending on the prescribed dose, by using a syringe needle and through the patient's skin.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global implantable drug delivery devices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Boston Scientific Corporation, Abbott Laboratories, Medtronic, Merck & Co., Bausch & Lomb Inc., Allergan, Inc., Psivida Corp., Bayer Healthcare, Alimera Sciences, Eyepoint Pharmaceuticals, Valeant Pharmaceuticals, DSM Biomedical, Delpor Inc., Teleflex Incorporated, and 3M Company
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global implantable drug delivery devices market report caters to various stakeholders in this industry including investors, suppliers, implantable drug delivery device manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the implantable drug delivery devices market
Market Segmentation
- By Product Type
- Drug Infusion Pumps
- Intraocular Drug Delivery Devices
- Contraceptive Drug Delivery Devices
- Stents
- By Technology
- Biodegradable Implants
- Non-biodegradable Implants
- By Application
- Ophthalmology
- Cardiovascular
- Birth Control/Contraception
- Others
- By Regional Insights:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Boston Scientific Corporation
- Abbott Laboratories
- Medtronic Plc.
- Merck & Co.
- Bausch & Lomb Inc.
- Allergan, Inc.
- Bayer Healthcare
- Alimera Sciences
- Eyepoint Pharmaceuticals
- DSM Biomedical
- Delpor Inc.
- Teleflex Incorporated
- 3M Company
Table of Contents
1. Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Market Trends
- Merger and Acquisitions
- New Product Approvals/Launch
- Technology Evolution
- PEST Analysis
- PORTER's Analysis
4. Global Implantable Drug Delivery Devices Market, By Product Type, 2026 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-O-Y Growth Analysis, 2021-2033
- Segment Trends
- Drug Infusion Pumps
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, (USD Bn)
- Intraocular Drug Delivery Devices
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, (USD Bn)
- Contraceptive Drug Delivery Devices
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, (USD Bn)
- Stents
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, (USD Bn)
5. Global Implantable Drug Delivery Devices Market, By Technology, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-O-Y Growth Analysis, 2021-2033
- Segment Trends
- Biodegradable Implants
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, (USD Bn)
- Non-biodegradable Implants
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, (USD Bn)
6. Global Implantable Drug Delivery Devices Market, By Application, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-O-Y Growth Analysis, 2021-2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, (USD Bn)
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, (USD Bn)
- Birth control/Contraception
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, (USD Bn)
7. Global Implantable Drug Delivery Devices Market, By Region, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2026-2033 (USD Bn)
- Market Size and Forecast, By Technology, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country, 2026-2033 (USD Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2026-2033 (USD Bn)
- Market Size and Forecast, By Technology, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country, 2026-2033 (USD Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2026-2033 (USD Bn)
- Market Size and Forecast, By Technology, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country, 2026-2033 (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product Type, 2026-2033 (USD Bn)
- Market Size and Forecast, By Technology, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country, 2026-2033 (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Product Type, 2026-2033 (USD Bn)
- Market Size and Forecast, By Technology, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country, 2026-2033 (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2026-2033 (USD Bn)
- Market Size and Forecast, By Technology, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country, 2026-2033 (USD Bn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Medtronic Plc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Merck & Co.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Bausch & Lomb Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Allergan, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Bayer Healthcare
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Alimera Sciences
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Eyepoint Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- DSM Biomedical
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Delpor Inc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Teleflex Incorporated
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- 3M Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Analyst Views
- Boston Scientific Corporation
9. Section
- References
- Research Methodology
- About us and Sales Contact
